← Compare landing
Adragos Pharma vs Halo Pharma
Side-by-side profile data from each company listing. Missing fields stay blank rather than filled with assumptions.
| Category | Adragos Pharma | Halo Pharma |
|---|---|---|
| Summary | Global CDMO headquartered in Munich offering end-to-end development and manufacturing for small molecules and biologics, including sterile/non-sterile liquids, solids, semi-solids, lyophilization, and prefilled syringes across seven facilities in Europe and Japan. | Halo Pharma provides end-to-end pharmaceutical development and manufacturing for small molecule therapeutics across solids, semi-solids, oral liquids, and sterile injectables, with two North American cGMP facilities and an accelerated 16–20 week tech transfer program. |
| Services |
|
|
| Modalities |
|
|
| Development capabilities |
|
|
| Manufacturing capabilities |
|
|
| Locations |
|
|
| Certifications | Data not yet provided. | Data not yet provided. |
Find similar companies
Markdown mirror: /compare/adragos-pharma/halo-pharma.md